We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

79 hedge funds and large institutions have $39.4M invested in Avid Bioservices, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more call options, than puts

Call options by funds: $639K | Put options by funds: $248K

7% less funds holding

Funds holding: 8579 (-6)

29% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 28

38% less capital invested

Capital invested by funds: $63.9M → $39.4M (-$24.5M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
2.29%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
8
Increased
20
Reduced
28
Closed
13
Calls
$639K
Puts
$248K
Net Calls
+$391K
Net Calls Change
+$261K
Name Holding Trade Value Shares
Change
Change in
Stake
LTFS
26
Ladenburg Thalmann Financial Services
Florida
$134K -$1.92K -171 -1%
FHC
27
First Heartland Consultants
Missouri
$117K
VKH
28
Virtu KCG Holdings
New York
$116K +$92.1K +8,225 +209%
SG Americas Securities
29
SG Americas Securities
New York
$108K +$127K +11,387 New
TRCT
30
Tower Research Capital (TRC)
New York
$104K +$123K +10,988 New
FIM
31
Freedom Investment Management
Connecticut
$101K +$99.7K +8,902 +527%
Bank of America
32
Bank of America
North Carolina
$95K -$287K -25,659 -72%
ProShare Advisors
33
ProShare Advisors
Maryland
$95K -$25.4K -2,268 -18%
ICAS
34
Investors Capital Advisory Services
Massachusetts
$86K
Stifel Financial
35
Stifel Financial
Missouri
$80K
U
36
UBS
Switzerland
$78K -$91.5K -8,170 -50%
FAAS
37
First Allied Advisory Services
California
$63K
Morgan Stanley
38
Morgan Stanley
New York
$62K +$20.5K +1,830 +40%
CS
39
Credit Suisse
Switzerland
$54K -$68.7K -6,138 -52%
GC
40
Guggenheim Capital
Illinois
$48K -$79.7K -7,120 -59%
Legal & General Group
41
Legal & General Group
United Kingdom
$48K +$55.3K +4,940 New
TFF
42
Timothy F. Fidgeon
$45K +$3.19K +285 +6%
RC
43
RegentAtlantic Capital
New Jersey
$40K
Group One Trading
44
Group One Trading
Illinois
$37K -$154K -13,722 -78%
TC
45
TFS Capital
Pennsylvania
$36K -$623K -55,633 -94%
ICOA
46
Investment Centers of America
North Dakota
$34K +$40K +3,571 New
PGFC
47
Peapack-Gladstone Financial Corp
New Jersey
$34K +$40K +3,571 New
M&T Bank
48
M&T Bank
New York
$29K +$33.7K +3,007 New
RCM
49
Rotella Capital Management
Washington
$28K +$33.2K +2,967 New
PFPT
50
Pinnacle Financial Partners (Tennessee)
Tennessee
$27K

CDMO Hedge Fund Activity: Q3 2014 in Review

79 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2014, worth a combined $39.4M — down 38% from $63.9M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CDMO and 8 opened new positions — a net loss of 5 holders — while 28 trimmed existing stakes and 20 added.

The largest buyer was BlackRock Institutional Trust, adding an estimated $480K. The largest seller was Sabby Management, exiting entirely with an estimated $7.03M sold.

  • 79 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2014, down from 85 in Q2 2014.
  • Funds reported $39.4M of Avid Bioservices, Inc. Common Stock stock for Q3 2014, down 38% quarter-over-quarter.
  • 8 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2014 and 13 closed out, a net change of -5 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2014 was BlackRock Institutional Trust, an estimated $480K added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q3 2014 was Sabby Management, an estimated $7.03M sold.

Based on aggregated 13F filings for Q3 2014.